HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ganzhe Liu Selected Research

mitogen-activated protein kinase kinase kinase 12

12/2021MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ganzhe Liu Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
12/2021
1Necrosis
01/2020
1Neoplasms (Cancer)
01/2020
1Ischemic Stroke
01/2020
1Inflammation (Inflammations)
01/2020
1Epilepsy (Aura)
11/2019

Drug/Important Bio-Agent (IBA)

2Mitogen-Activated Protein KinasesIBA
12/2021 - 11/2019
1mitogen-activated protein kinase kinase kinase 12IBA
12/2021
1InterleukinsIBA
01/2020
1NADP (NADPH)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Kainic Acid (Kainate)IBA
11/2019